Early Prediction of Response to Chemoradiotherapy for Head and Neck Cancer Reliability of Restaging With Combined Positron Emission Tomography and Computed Tomography

被引:33
|
作者
Malone, James P. [1 ]
Gerberi, Michael A. T. [1 ]
Vasireddy, Syam [2 ,4 ]
Hughes, Larry F. [1 ]
Rao, Krishna [3 ]
Shevlin, Bruce [5 ]
Kuhn, Matthew [2 ,4 ]
Collette, Dean [2 ,4 ]
Tennenhouse, Joel [2 ,4 ]
Robbins, K. Thomas [1 ]
机构
[1] So Illinois Univ, Sch Med, Dept Surg, Springfield, IL 62794 USA
[2] So Illinois Univ, Sch Med, Dept Radiol, Springfield, IL 62794 USA
[3] So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL 62794 USA
[4] St Johns Hosp, Dept Radiol, Springfield, IL USA
[5] St Johns Hosp, Dept Radiat Oncol, Springfield, IL USA
关键词
SQUAMOUS-CELL CARCINOMA; STAGE-IV HEAD; RADIATION-THERAPY; FOLLOW-UP; FDG PET; DISSECTION; CHEMORADIATION; RADIOTHERAPY; UTILITY; CT;
D O I
10.1001/archoto.2009.152
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To assess the role of combined positron emission tomography and computed tomography (PET-CT) in predicting early treatment response at the primary site and in the neck after chemoradiotherapy (CRT) for advanced squamous cell carcinoma of the head and neck (SCCHN). Design: Retrospective analysis with a median follow-up of 24 months. Setting: Academic, tertiary referral center. Patients and Interventions: Thirty-one patients who were treated with concomitant intra-arterial CRT underwent PET-CT 6 to 8 weeks after the completion of treatment. Patients with findings on the physical examination, CT, or PET-CT indicative of persistent disease underwent appropriate surgical intervention for pathological assessment. Patients with a complete clinical response were observed with routine follow-up physical examination for disease recurrence. No evidence of disease at least 6 months after the completion of PET-CT was considered confirmation of complete clinical response. Main Outcome Measures: Presence or absence of residual or recurrent disease during the follow-up period was used to calculate the sensitivity, specificity, and positive and negative predictive values of PET-CT for the primary site and the neck. Results: Assessment of tumor response at the primary site with PET-CT had a sensitivity, specificity, and positive and negative predictive values of 83%, 54%, 31%, and 92%, respectively. In patients with pretreatment N1 to N3 disease, the sensitivity, specificity, and positive and negative predictive values of posttreatment PET-CT were 75%, more than 94%, more than 75%, and 94%, respectively, and the specificity and negative predictive value for patients with pretreatment N0 disease in the neck were 92% and more than 92%, respectively. Conclusions: Negative PET-CT findings accurately determine early disease response at the primary site and in the neck. False-positive findings are common at the primary site. Patients with a negative PET-CT finding after the completion of intra-arterial CRT do not require surgical intervention.
引用
收藏
页码:1119 / 1125
页数:7
相关论文
共 50 条
  • [31] In Response to combination of panendoscopy and positron emission tomography/computed tomography increases detection of unknown primary head and neck carcinoma
    Sokoya, Mofiyinfolu
    Kadakia, Sameep
    Ducic, Yadranko
    Chowdhury, Farshad
    LARYNGOSCOPE, 2019, 129 (04): : E121 - E121
  • [32] Positron Emission Tomography and Stage Migration in Head and Neck Cancer
    VanderWalde, Noam A.
    Salloum, Ramzi G.
    Liu, Tsai-Ling
    Hornbrook, Mark C.
    Rosetti, Maureen C. O'Keeffe
    Ritzwoller, Debra P.
    Fishman, Paul A.
    Lafata, Jennifer Elston
    Khandani, Amir H.
    Chera, Bhishamjit S.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2014, 140 (07) : 654 - 661
  • [33] Role of positron emission tomography (PET) in head and neck cancer
    Duet, M.
    Hugonnet, F.
    Faraggi, M.
    EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2010, 127 (01) : 40 - 45
  • [34] Positron-emission tomography for surveillance of head and neck cancer
    Ryan, WR
    Fee, WE
    Le, QT
    Pinto, HA
    LARYNGOSCOPE, 2005, 115 (04): : 645 - 650
  • [35] Positron emission tomography and stage migration for head and neck cancer
    VanderWalde, Noam Avraham
    Salloum, Ramzi George
    Liu, Tsai-Ling
    Hornbrook, Mark Christopher
    O'Keeffe-Rosetti, Maureen Cecelia
    Ritzwoller, Debra Pearson
    Fishman, Paul Arthur
    Lafata, Jennifer Elston
    Khandani, Amir H.
    Chera, Bhishamjit S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study
    Van den Wyngaert, Tim
    Helsen, Nils
    Carp, Laurens
    Hakim, Sara
    Martens, Michel J.
    Hutsebaut, Isabel
    Debruyne, Philip R.
    Maes, Annelies L. M.
    van Dinther, Joost
    Van Laer, Carl G.
    Hoekstra, Otto S.
    De Bree, Remco
    Meersschout, Sabine A. E.
    Lenssen, Olivier
    Vermorken, Jan B.
    Van den Weyngaert, Danielle
    Stroobants, Sigrid
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (30) : 3458 - +
  • [37] The Evolving Role of Positron Emission Tomography-Computed Tomography in Organ-Preserving Treatment of Head and Neck Cancer
    Garg, Madhur K.
    Glanzman, Jonathan
    Kalnicki, Shalom
    SEMINARS IN NUCLEAR MEDICINE, 2012, 42 (05) : 320 - 327
  • [38] Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence
    Ho, Allen S.
    Tsao, Gabriel J.
    Chen, Frank W.
    Shen, Tianjie
    Kaplan, Michael J.
    Colevas, A. Dimitrios
    Fischbein, Nancy J.
    Quon, Andrew
    Quynh-Thu Le
    Pinto, Harlan A.
    Fee, Willard E., Jr.
    Sunwoo, John B.
    Sirjani, Davud
    Hara, Wendy
    Yao, Mike
    CANCER, 2013, 119 (07) : 1349 - 1356
  • [39] Improvement of Imaging Conditions to Improve the Detection Rate of Head and Neck Cancer by Positron Emission Tomography/Computed Tomography Examination
    Odagiri, Hayato
    Takanami, Kentaro
    Kaneta, Tomohiro
    Usui, Akihito
    Kojima, Ikuho
    Kodama, Hiroyasu
    Saitou, Shin
    Tanaka, Yoshitaka
    Dendo, Yutaka
    Takase, Kei
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2023, 260 (02): : 141 - 147
  • [40] Positron Emission Tomography/Computed Tomography and Biomarkers for Early Treatment Response Evaluation in Metastatic Colon Cancer
    Engelmann, Bodil E.
    Loft, Annika
    Kjaer, Andreas
    Nielsen, Hans J.
    Gerds, Thomas A.
    Benzon, Eric V.
    Brunner, Nils
    Christensen, Ib J.
    Hansson, Susanne H.
    Hollander, Niels H.
    Kristensen, Michael H.
    Lofgren, Johan
    Markova, Elena
    Sloth, Carsten
    Hojgaard, Liselotte
    ONCOLOGIST, 2014, 19 (02): : 164 - 172